Mackenzie Financial’s Denali Therapeutics DNLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-8,256
Closed -$240K 1722
2024
Q3
$240K Buy
+8,256
New +$205K ﹤0.01% 1287
2024
Q2
Sell
-10,560
Closed -$217K 1561
2024
Q1
$217K Buy
+10,560
New +$198K ﹤0.01% 1308
2023
Q3
Sell
-10,465
Closed -$311K 1501
2023
Q2
$311K Buy
+10,465
New +$294K ﹤0.01% 1162
2023
Q1
Sell
-7,959
Closed -$221K 1543
2022
Q4
$221K Buy
7,959
+1,438
+22% +$42.8K ﹤0.01% 1210
2022
Q3
$200K Sell
6,521
-377
-5% -$12.3K ﹤0.01% 1252
2022
Q2
$203K Buy
+6,898
New +$181K ﹤0.01% 1281
2022
Q1
Sell
-7,331
Closed -$327K 1433
2021
Q4
$327K Sell
7,331
-143
-2% -$6.78K ﹤0.01% 1108
2021
Q3
$377K Buy
7,474
+3,549
+90% +$200K ﹤0.01% 1050
2021
Q2
$308K Buy
+3,925
New +$243K ﹤0.01% 1065

Other funds holding DNLI